Iradimed (IRMD) Net Income towards Common Stockholders Growth (5y) (2018 - 2026)
Powered by 
Analysis
Iradimed (IRMD) Net Income towards Common Stockholders Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.84% |
| Mar 31, 2026 | 33.21% |
| Dec 31, 2025 | 44.05% |
| Sep 30, 2025 | 39.00% |
| Jun 30, 2025 | 36.47% |
| Mar 31, 2025 | 21.51% |
| Dec 31, 2024 | 6.54% |
| Sep 30, 2024 | 15.52% |
| Jun 30, 2024 | 18.60% |
| Mar 31, 2024 | 17.52% |
| Dec 31, 2023 | 12.80% |
| Sep 30, 2023 | 16.12% |
| Jun 30, 2023 | 25.27% |
| Mar 31, 2023 | 32.27% |
| Dec 31, 2022 | 160.64% |
| Sep 30, 2022 | 77.89% |
| Jun 30, 2022 | 55.45% |
| Mar 31, 2022 | 66.14% |
| Dec 31, 2021 | 46.86% |
| Sep 30, 2021 | 10.55% |